Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
Acetaminophen, Caffeine, and 8 mg of Codeine Phosphate Tablets (sold under the following trademarks: Life, Exact, Encounter, Rexall) (January 18, 2011)
- Starting date:
- January 18, 2011
- Posting date:
- February 07, 2011
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-2011A19
Reason
These lots shows evidence of contamination and were released without conducting a root cause investigation and impact assessment. Tablets with red and black spots had been reported.
Depth of distribution
Pharmacies across Canada.
Affected products
Acetaminophen, Caffeine, and 8 mg of Codeine Phosphate Tablets (sold under the following trademarks: Life, Exact, Encounter, Rexall)
DIN, NPN, DIN-HIM
DIN 02251914
Dosage form
Tablets
Strength
- Acetaminophen 300 mg
- Caffeine 15 mg
- Codeine Phosphate 8 mg
Lot or serial number
F-37022, F-37119, F-37138, F-37178, F-39603, F-37011
Companies
- Recalling Firm
- Pharmetics Inc.
3695 Laurentides Highway
Laval Quebec
Canada H7L 3H7
- Marketing Authorization Holder
- Pharmetics Inc.
3695 Laurentides Highway
Laval Quebec
Canada H7L 3H7
- Date modified: